Login / Signup

Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis.

Su Jin HamDaewon LeeWen Jun XuEunjoo ChoSekyu ChoiSoohong MinSunghyouk ParkJongkyeong Chung
Published in: Science advances (2021)
The role of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1; also called PARK5) in the pathogenesis of Parkinson's disease (PD) has been controversial. Here, we find that the loss of UCHL1 destabilizes pyruvate kinase (PKM) and mitigates the PD-related phenotypes induced by PTEN-induced kinase 1 (PINK1) or Parkin loss-of-function mutations in Drosophila and mammalian cells. In UCHL1 knockout cells, cellular pyruvate production and ATP levels are diminished, and the activity of AMP-activated protein kinase (AMPK) is highly induced. Consequently, the activated AMPK promotes the mitophagy mediated by Unc-51-like kinase 1 (ULK1) and FUN14 domain-containing 1 (FUNDC1), which underlies the effects of UCHL1 deficiency in rescuing PD-related defects. Furthermore, we identify tripartite motif-containing 63 (TRIM63) as a previously unknown E3 ligase of PKM and demonstrate its antagonistic interaction with UCHL1 to regulate PD-related pathologies. These results suggest that UCHL1 is an integrative factor for connecting glycolysis and PD pathology.
Keyphrases
  • protein kinase
  • drug induced
  • skeletal muscle
  • diabetic rats
  • cell proliferation
  • tyrosine kinase
  • signaling pathway
  • oxidative stress
  • mouse model
  • small molecule
  • radiation therapy
  • endothelial cells